Localized PD-1 CAR T therapy reprograms neuroinflammation.

Shalita R, Ben Yehuda M, Gur C, Frid Y, McGrath S, Suhler R, Bolokan L, Eisenberg V, Eshed R S, Shlomi-Loubaton S, et al.